Trump adviser described as ‘key architect’ of drug-pricing blueprint to step down
By Admin | August 14, 2019
John O'Brien, a former insurance industry executive, will step down less than one year after his appointment as senior advisory to HHS Secretary Alex Azar on drug-pricing reform. He had worked for HHS since March 2017 and also previously worked for CMS.
For more information please read, Trump adviser described as ‘key architect’ of drug-pricing blueprint to step down, by MedCity News.
